| Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease A Swaminathan, GM Borichevsky, TS Edwards, E Hirschfeld, TC Mules, ... Journal of Crohn's and Colitis 16 (12), 1862-1873, 2022 | 38 | 2022 |
| The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease—results from the Stress, Anxiety and Depression with … TC Mules, A Swaminathan, E Hirschfeld, G Borichevsky, C Frampton, ... Alimentary pharmacology & therapeutics 55 (2), 201-211, 2022 | 34 | 2022 |
| The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course A Swaminathan, D Fan, GM Borichevsky, TC Mules, E Hirschfeld, ... Alimentary Pharmacology & Therapeutics 56 (4), 664-674, 2022 | 29 | 2022 |
| The impact of disease activity on sexual and erectile dysfunction in patients with inflammatory bowel disease TC Mules, A Swaminathan, E Hirschfeld, GM Borichevsky, CM Frampton, ... Inflammatory bowel diseases 29 (8), 1244-1254, 2023 | 16 | 2023 |
| The disease severity index for inflammatory bowel disease is a valid instrument that predicts complicated disease A Swaminathan, JM Fulforth, CM Frampton, GM Borichevsky, TC Mules, ... Inflammatory bowel diseases, izad294, 2023 | 9 | 2023 |
| Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease A Swaminathan, GM Borichevsky, CM Frampton, AS Day, MB Hampton, ... Inflammatory Bowel Diseases, izae032, 2024 | 7 | 2024 |
| Su1917 faecal myeloperoxidase-a potential non-invasive biomarker of disease activity in inflammatory bowel diseasE (IBD) A Swaminathan, G Borichevsky, T Hoskin, T Mules, AS Day, M Hampton, ... Gastroenterology 158 (6), S-701, 2020 | 1 | 2020 |
| Development and investigation of a non-invasive disease severity index for inflammatory bowel disease A Swaminathan, GM Borichevsky, C Frampton, AJ Kettle, ... Journal of Crohn's and Colitis, jjae106, 2024 | | 2024 |
| Sa1824 A NON-INVASIVE INFLAMMATORY BOWEL DISEASE SEVERITY INDEX CAN HELP PREDICT A COMPLICATED COURSE OF ILLNESS A Swaminathan, G Borichevsky, C Frampton, MB Hampton, A Kettle, ... Gastroenterology 166 (5), S-537-S-538, 2024 | | 2024 |
| Su1791 THE DISEASE SEVERITY INDEX FOR INFLAMMATORY BOWEL DISEASE-A VALID AND RELIABLE INSTRUMENT ENCAPSULATING THE BURDEN OF ILLNESS A Swaminathan, J Fulforth, C Frampton, G Borichevsky, T Mules, ... Gastroenterology 164 (6), S-683, 2023 | | 2023 |
| The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease (Sept, 10.1093/ibd/izac204, 2022) TC Mules, A Swaminathan, E Hirschfeld, GM Borichevsky, CM Frampton, ... INFLAMMATORY BOWEL DISEASES 29 (2), 337-337, 2023 | | 2023 |
| Response to: Evaluating Discriminative Accuracy of Biomarkers in Relation to Binary Study Outcomes: First Validate, Then Celebrate? A Swaminathan, CM Frampton, GM Borichevsky, AJ Kettle, RB Gearry Journal of Crohn's and Colitis 17 (1), 147-148, 2023 | | 2023 |
| Sa1789 THE IMPACT OF INFLAMMATORY BOWEL DISEASE ACTIVITY ON ANXIETY AND DEPRESSION-RESULTS FROM SEXUAL FUNCTION, ANXIETY AND DEPRESSION WITH DISEASE ACTIVITY (SADD) STUDY T Mules, A Swaminathan, G Borichevsky, C Frampton, R Gearry Gastroenterology 158 (6), S-424, 2020 | | 2020 |
| Myeloperoxidase, calprotectin and oxidants in inflammatory bowel disease GM Borichevsky University of Otago, 0 | | |
